Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
FTS International chapter 11 filing
Davis Polk is advising an ad hoc group of holders of senior secured notes in connection with the chapter 11 restructuring of…
Hologic $950 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by…
Advance Auto Parts $350 million notes offering and concurrent cash tender offer
Davis Polk advised the joint book-running managers in connection with an offering by Advance Auto Parts, Inc. of $350…
Kemper $400 million senior notes offering
Davis Polk advised the underwriters in connection with an offering by Kemper Corporation of $400 million aggregate…
Kingsoft Cloud Holdings $509 million follow-on offering of ADSs
Davis Polk advised Kingsoft Cloud Holdings Limited and certain selling shareholders on its approximately $509 million SEC…
Toronto-Dominion Bank $500 million notes offering
Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $500 million aggregate principal amount of…
Zai Lab HK$5.94 billion secondary listing and IPO on the HKEX
Davis Polk advised Zai Lab Limited in connection with its secondary listing and initial public offering on the Hong Kong…
ADC Therapeutics $204 million SEC-registered offering
Davis Polk advised ADC Therapeutics SA on its SEC-registered offering of 6,000,000 common shares for total gross…
Toronto-Dominion Bank $500 million notes offering
Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $500 million aggregate principal amount of…
ADC Therapeutics $204 million SEC-registered offering
Davis Polk advised ADC Therapeutics SA on its SEC-registered offering of 6,000,000 common shares for total gross…